Indegene Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The Indegene Q2 results FY27 announcement is the next scheduled earnings event for Indegene Ltd., a digital-first commercialisation services company for the life sciences industry, handling medical affairs, regulatory operations, pharmacovigilance and omnichannel marketing for global pharmaceutical and medical device firms. The stock traded at Rs 577.80 on the NSE on 10 September 2026, up 0.50% from the previous close of Rs 574.90, about 18.0% below its 52-week high of Rs 705.00 and 54.1% above its 52-week low of Rs 375.00.

What makes the Indegene Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 804.00 crore of revenue and a profit of Rs 102.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 1,063.00 crore and a profit of Rs 116.00 crore. Everything below is built from those reported figures rather than from any forecast.

Click Here – Get Free Investment Predictions

When Is the Indegene Q2 Results FY27 Date?

The Indegene Q2 results date for FY27 is not confirmed. As of 10 September 2026, Indegene Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.

What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Indegene Q2 results date becomes public through that filing rather than through any advance announcement.

The Indegene Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Indegene.

Indegene Q2 Results Expectations: What the Market Is Actually Tracking

No verified analyst estimate for the Indegene Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Indegene. The Indegene Q2 results watchlist below is built from what the company has actually reported and disclosed.

The first is revenue, which was Rs 804 crore in September 2025 against Rs 1,063 crore in Q1 FY27, a rise of about 32%. Sales stepped up 17.2% in December 2025 alone after four quarters of 5% to 6% growth.

The second is the operating margin, which was 17% in September 2025 and 16% in Q1 FY27. Margin has compressed steadily from 20% in June 2025, so a 40% rise in sales produced only a 12% rise in operating profit.

The third is that reported earnings per share has gone backwards despite that growth, from Rs 4.85 in June 2025 to Rs 4.82 in June 2026. Depreciation jumped 74% in December 2025, from Rs 23 crore to Rs 40 crore, and has stayed at the higher level since.

Check Indegene Ltd. Live Fundamentals on the Univest Screener

Indegene Q2 Results Preview: The Q1 FY27 Actuals It Builds On

Indegene Ltd. reported revenue of Rs 1,063.00 crore in Q1 FY27, up 39.68% from Rs 761.00 crore in Q1 FY26, and a profit of Rs 116.00 crore at the net level, up 0.00% from Rs 116.00 crore in Q1 FY26. These are reported actuals, not estimates.

Sequentially, revenue was up 5.98% over the March 2026 quarter figure of Rs 1,003.00 crore, and net profit was up 45.00% from Rs 80.00 crore in Q4 FY26. Operating margin stood at 16% in Q1 FY27 against 17% in the September 2025 quarter, which is the comparison the Indegene Q2 results print will be read against.

Q2 FY26 Base: The Comparison Indegene Q2 Results FY27 Must Beat

Indegene Ltd. reported revenue of Rs 804.00 crore and a profit of Rs 102.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Indegene Q2 results preview.

Net profit in that base quarter was below the Rs 116.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 804.00 crore sits below the Rs 1,063.00 crore of the June 2026 quarter, which frames how much sequential movement the Indegene Q2 results print needs to show growth.

Indegene Quarterly Results Trend Over the Last Four Quarters

Quarter	Revenue (Rs Cr)	Net Profit (Rs Cr)
Q2 FY26 (Sep 2025)	804.00	102.00
Q3 FY26 (Dec 2025)	942.00	103.00
Q4 FY26 (Mar 2026)	1,003.00	80.00
Q1 FY27 (Jun 2026)	1,063.00	116.00

Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company's exchange filings, and they are the only basis this Indegene Q2 results preview uses.

Revenue across those four quarters ranged from Rs 804.00 crore to Rs 1,063.00 crore, and net profit from Rs 80.00 crore to Rs 116.00 crore. That spread is the honest context for the Indegene Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.

Key Factors That Could Shape Indegene Q2 Results FY27

The Indegene Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Indegene has already reported.

Pharmaceutical Marketing Budgets Set Demand

Work is commissioned by global drug companies around product launches, label changes and market expansion, so their commercial spending decides the volume. Patent expiries and pipeline timing move that spending from year to year.

The December 2025 Step Changed the Cost Base

Revenue rose Rs 138 crore and depreciation rose Rs 17 crore in the same quarter, and depreciation has stayed roughly Rs 20 crore a quarter above its earlier run rate. That combination is consistent with something new being consolidated from that point.

One Line Explains the March 2026 Dip

Other income was negative Rs 10 crore that quarter against positive Rs 19 crore before and Rs 29 crore after, which is why net profit fell 22% to Rs 80 crore while sales rose. The effective tax rate held steady at 23% to 24% throughout.

Indegene Q2 Results FY27: Share Price and Valuation Going Into the Print

Indegene share price today is Rs 577.80 on the NSE, up Rs 2.90 or 0.50% from the previous close of Rs 574.90 on 10 September 2026, ahead of the Indegene Q2 results announcement.

Metric	Value (10 September 2026)
NSE Symbol	INDGN
Current Market Price	Rs 577.80
52-Week High	Rs 705.00
52-Week Low	Rs 375.00
Market Capitalisation	Rs 13,923 crore
PE Ratio	33.48
PB Ratio	4.44
EPS (TTM)	Rs 17.26
Book Value per Share	Rs 130.00
Debt to Equity	0.05
Return on Equity	14.4%
50-Day Moving Average	Rs 544.49
200-Day Moving Average	Rs 511.28
RSI (14)	55.37

The stock trades above both its 50-day average of Rs 544.49 and its 200-day average of Rs 511.28, with a 14-day RSI of 55.37. None of this is a view on where the shares go once the Indegene Q2 results are announced, and no price target is offered here.

Download the Univest iOS App or Univest Android App to track Indegene Ltd. live price and quarterly earnings updates.

What Investors Should Watch When Indegene Q2 Results Are Announced

Four lines carry most of the information in a company of this size, and reading them in order keeps the Indegene Q2 results print in proportion.

1. Revenue against the Rs 804.00 crore reported in the September 2025 base quarter
2. Net profit against a profit of Rs 102.00 crore in that same quarter
3. Operating margin against 16% in Q1 FY27
4. Any exceptional item, provision or one-off gain disclosed alongside the numbers

A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Indegene Q2 results announcement should be read together with the notes to the results rather than the headline alone.

Conclusion on Indegene Q2 Results FY27

The Indegene Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Indegene Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.

On that basis the Indegene Q2 results FY27 print faces a base of Rs 804.00 crore in revenue and a profit of Rs 102.00 crore, with the most recent quarter having delivered Rs 1,063.00 crore and a profit of Rs 116.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Indegene, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.

FAQs on Indegene Q2 Results FY27

What is the Indegene Q2 results date for FY27?

Ans. The Indegene Q2 results date for FY27 is not confirmed. Indegene Ltd. had not filed a board meeting intimation with the NSE or BSE as of 10 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.

What quarter do the Indegene Q2 results 2026 cover?

Ans. The Indegene Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Indegene Ltd. reports revenue, operating profit and net profit for that period, and the Indegene Q2 results filing also carries the notes to the accounts.

What were the Indegene Q1 FY27 results?

Ans. Indegene Ltd. reported revenue of Rs 1,063.00 crore in Q1 FY27 and a profit of Rs 116.00 crore at the net level. Revenue was up 39.68% versus Q1 FY26 and net profit was up 0.00% from Rs 116.00 crore in Q1 FY26.

What were Indegene Q2 FY26 results in the September 2025 quarter?

Ans. Indegene Ltd. reported revenue of Rs 804.00 crore and a profit of Rs 102.00 crore in Q2 FY26. Operating margin was 17%. Those figures form the base for the Indegene Q2 results FY27 comparison.

What are the main Indegene Q2 results expectations this quarter?

Ans. No verified analyst estimate is publicly available. The Indegene Q2 results expectations centre on revenue against the Rs 804.00 crore base, net profit against a profit of Rs 102.00 crore, operating margin against 16% in Q1 FY27, and any exceptional item disclosed with the numbers.

What is Indegene share price today ahead of the Q2 earnings?

Ans. Indegene share price is Rs 577.80 on the NSE as of 10 September 2026, up 0.50% from Rs 574.90. The stock is about 18.0% below its 52-week high of Rs 705.00 and 54.1% above its 52-week low of Rs 375.00, at a market capitalisation of Rs 13,923 crore.

Is Indegene a good stock to buy before the Q2 results?

Ans. This article does not offer a buy, sell or hold recommendation on Indegene Ltd. The stock trades at a price-to-book ratio of 4.44 with a return on equity of 14.4%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.